GBA1 and Parkinson disease: GBA1 mutations are estimated to increase the risk of developing PD by 20–30‐fold, and it is reported that 7%–10% of all PD patients carry heterozygous GBA1 mutations (Nalls et al., 2013; Sidransky et al., 2009).